Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
-
Published:2024-04
Issue:
Volume:Volume 16
Page:223-231
-
ISSN:1179-1314
-
Container-title:Breast Cancer: Targets and Therapy
-
language:en
-
Short-container-title:BCTT
Author:
Chen Ying, Li Wen-Xia, Wu Jia-Hua, Chen Geng-Hang, Yang Chun-Min, Lu Hai, Wang Xi, Wang Shu-Sen, Huang Heng, Cai Li, Zhao Li, Peng Rou-Jun, Lin Ying, Tang Jun, Zeng Jian, Zhang Le-Hong, Ke Yong-Li, Wang Xian-Ming, Liu Xin-Mei, Zhang An-Qin, Xu FeiORCID, Bi Xi-Wen, Huang Jia-Jia, Li Ji-BinORCID, Pang Dan-Mei, Xue CongORCID, Shi Yan-Xia, He Zhen-YuORCID, Lin Huan-XinORCID, An XinORCID, Xia Wen, Cao Ye, Guo Ying, Hong Ruo-Xi, Jiang Kui-KuiORCID, Zhong Yong-Yi, Zhang Ge, Tienchaiananda Piyawan, Oikawa Masahiro, Yuan Zhong-Yu, Chen Qian-Jun
Publisher
Informa UK Limited
|
|